You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
AbbVie announces quarterly cash dividend
12 September 2022 -

AbbVie Inc. (NYSE: ABBV), a US-based biopharmaceutical company, announced on Friday its quarterly cash dividend.

The company has declared a cash dividend of USD1.41 per share. The dividend will be paid to shareholders of record as at 14 October 2022, on 15 November 2022.

Login
Username:

Password:


Related Headlines

Nordic Nanovector ASA reports full year results for 2022

Devyser Diagnostics AB announces full year 2022 results

Abbott announces quarterly common dividend

AbbVie Inc announces quarterly cash dividend

Qilian International announces special one-time cash dividend

Sesen Bio and Carisma Therapeutics Increase Special Cash Dividend, Gain Stockholder Support for Pending Merger

Eli Lilly collaborates with International Agencies (Bangladesh) Ltd

Cardinal Health announces quarterly dividend

Sanofi reports Q4 sales of Dupixent up 42%

Turbine's AI-powered Cancer Cell Simulations Will Be Used to Identify Novel Disease Positioning Strategies in Cancer Research UK's Latest Biotech Partnership

Sesen Bio, Carisma Therapeutics Announce Increase to Expected Special Cash Dividend in Connection with Pending Merger

AmeriHealth Caritas Promotes Access to COVID-19 Vaccines for Children Ahead of the Winter Months

Eli Lilly collaborates with EVA Pharma to deliver sustainable supply of affordable insulin to Africa

Amgen announces Q1 2023 dividend

Eli Lilly increases Q1 2023 quarterly dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023